Subscribe to My Feed
Loading ...Fiocruz Gets Green Light to Produce AIDS Medicine Under Compulsory License
Wednesday, January 28th, 2009Brazil’s National Sanitary Vigilance Agency (ANVISA) has authorized the Pharmaceutical Technology Institute (“Farmanguinhos“) of the Oswaldo Cruz Foundation (“Fiocruz“) to begin producing the antiretriviral drug Efavirenz. About 80,000 Brazilian HIV-positive patients currently receive the drug through the National Program on Sexually-Transmitted Diseases (STDs) and AIDS. To refresh memories, Efavirenz is the AIDS drug for which […]
Brazil Proceeds with Compulsory Licensing of Antiretroviral Drug / Brasil continua com a licença compulsória de medicamento antiretroviral
Monday, October 6th, 2008Temas Observation: All developing nations have had the clear right to resort to compulsory licensing of pharmaceuticals since the adoption of the Doha Declaration by the World Trade Organization (WTO) in 2001. Brazil has long reserved this right under its own laws, although previously it has been hesitant to actually use the power, preferring instead […]
Cheaper HIV/AIDS Treatments for LAC Nations
Thursday, June 7th, 2007In May former US President Bill Clinton announced that his foundation had negotiated new agreements to substantially reduce the price of 15 so-called “second-line treatments” for HIV/AIDS, plus a new, “next generation” once-a-day pill, for 66 poor and middle-income countries. The 66 (chosen because they represent about 90% of the world’s AIDS cases) includes many […]